Debe informar a su médico si piensa que está (o podría quedarse) embarazada. Perindopril/Indapamida Viso Farmacéutica no está recomendado al principio del embarazo, y no lo debe tomar si está embarazada de más de 3 meses, ya que puede causar un daño grave a su bebé si se usa en ese periodo (ver “Embarazo y lactancia”).
Cuando esté tomando Perindopril / Indapamida Viso Farmacéutica, también debe informar a su médico o al personal sanitario:
Los deportistas deben saber que Perindopril / Indapamida Viso Farmacéutica contiene un principio activo (indapamida) que puede dar positivo en las pruebas de dopaje.
Niños y adolescentes
Perindopril / Indapamida Viso Farmacéutica no debe administrarse a niños y adolescentes.
Otros medicamentos y Perindopril / Indapamida Viso FarmacéuticaInforme a su médico o farmacéutico si está utilizando, ha utilizado recientemente o pudiera tener que utilizar cualquier otro medicamento,.
Debe evitar tomar Perindopril / Indapamida Viso Farmacéutica con:
El tratamiento con Perindopril / Indapamida Viso Farmacéutica puede verse afectado por otros medicamentos. Puede que su médico deba modificar su dosis y/o tomar otras precauciones. Si toma alguno de los siguientes medicamentos, asegúrese de comunicárselo a su médico, ya que puede precisar atención especial:
Toma de Perindopril / Indapamida Viso Farmacéutica con alimentos y bebidas
Es preferible tomar Perindopril / Indapamida Viso Farmacéutica antes de una comida.
Embarazo y lactancia
Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar cualquier medicamento.
Embarazo
Debe informar a su médico sicree que está (o podría quedarse)embarazada. Su médico le recomendará que deje de tomar Perindopril / Indapamida Viso Farmacéutica antes de quedarse embarazada o en cuanto sepa que está embarazada y le aconsejará tomar otro medicamento en su lugar. Perindopril / Indapamida Viso Farmacéutica no está recomendado al principio del embarazo y no debe tomarlo cuando esté embarazada de más de tres meses, ya que puede causar un daño grave a su bebé si se toma después del tercer mes de embarazo.
Lactancia
Perindopril / Indapamida Viso Farmacéuticano está recomendado si está en periodo de lactancia.
Informe a su médico inmediatamente si va a empezar o si está en periodo de lactancia.
Acuda a su médico inmediatamente
Conducción y uso de máquinas
Perindopril / Indapamida Viso Farmacéutica generalmente no afecta al estado de alerta, sin embargo, en ciertos pacientes pueden ocurrir diferentes reacciones, como mareos o debilidad, debidas al descenso de la tensión arterial. Como resultado, es posible que la capacidad para conducir o para utilizar máquinas se vea mermada.
Perindopril / Indapamida Viso Farmacéutica contiene lactosa
Si su médico le ha indicado que padece una intolerancia a ciertos azúcares, consulte con él antes de tomar este medicamento.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is one tablet once a day. Your doctor may decide to modify the dose if you have kidney insufficiency. Take the tablet as possible in the morning before eating. Swallow the tablet with a glass of water.
If you take more Perindopril / Indapamida Viso Farmacéutica than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. The most probable effect in case of overdose is a drop in blood pressure. If a significant drop in blood pressure occurs (associated with nausea, vomiting, cramps, dizziness, drowsiness, mental confusion, changes in the amount of urine produced by the kidneys), lying down with legs elevated may help.
If you forgot to take Perindopril / Indapamida Viso Farmacéutica
It is essential to take your medication every day, as regular treatment is more effective. However, if you forget to take one tablet of perindopril / indapamida, take the next dose at the usual time. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Perindopril / Indapamida Viso Farmacéutica
Since high blood pressure treatment is generally lifelong, you should consult your doctor before interrupting treatment with this medication.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking the medicine and contact your doctor immediately if you experience any of the following serious side effects:
In decreasing order of frequency, other side effects are as follows:
Common(may affect up to 1 in 10 patients):
Uncommon(may affect up to 1 in 100 patients):
Rare(may affect up to 1 in 1,000 patients):
Very Rare(may affect up to 1 in 10,000 patients):
Frequency not known(the frequency cannot be estimated from the available data)
If you have these symptoms, contact your doctor as soon as possible.
Reporting of adverse reactions
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is a possible adverse reaction that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaram.es. By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Store in the original packaging to protect it from moisture.
This medication does not require any special storage conditions as long as the protective bag remains unopened. Once opened, the blisters must be stored in the outer packaging at a temperature below 30°C. Unused tablets must be discarded 2 months after opening the protective bag.
Do not use this medication after the expiration date appearing on the label, blister, bag, or packaging, after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown away through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. In this way, you will help protect the environment.
Composition of Perindopril / Indapamida Viso Pharmaceutical 2 mg/0.625 mg tablets
Lactose monohydrate
Magnesium stearate
Hydrophobic colloidal silica
Microcrystalline cellulose
Appearance of the product and contents of the package
Perindopril / Indapamida Viso Pharmaceutical 2 mg/0.625 mg are capsule-shaped tablets, white, marked with a ‘P’ to the left and an ‘I’ to the right of the groove on one face, and grooved on the other face. The tablet can be divided into two equal halves.
The tablets are presented in PVC/PVDC-Aluminium blisters with an aluminium protective bag, including a desiccant to protect the tablets from moisture. Do not ingest the desiccant.
Package sizes
2 mg/0.625 mg 20, 30, 90 and 100 tablets.
*Some package sizes may only be marketed.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization:
Glenmark Arzneimittel GmbH
Industriestr. 31,
82194 Gröbenzell,
Germany
Responsible manufacturer:
Glenmark Pharmaceuticals S.R.O.
Fibichova 143
56617 Vysoke Myto
Czech Republic
Or
Glenmark Pharmaceuticals Europe Limited
Building 2, Croxley Green Business Park,
Croxley Green
Hertfordshire, WD18 8YA
United Kingdom
Further information about this medicinal product can be obtained by contacting the local representative of the holder of the marketing authorization:
Viso Farmacéutica S.L.U.
c/ Retama 7, 7th Floor,
28045 Madrid,
Spain
This pharmaceutical product is authorized in the member states of the European Economic Area with the following names:
ItalyPerindopril E Indapamide EG 2/0.625mg
NetherlandsPerindopril tert-butylamine /Indapamide Glenmark 2/0.625mg Tabletten
SpainPerindopril/Indapamida Viso Farmaceutica 2/0,625 mg tablets EFG
Last review date of this leaflet:October 2022.
Detailed information about this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.